Preparing for China · patient guide

Records checklist for a liver cancer second opinion

A useful liver cancer second opinion depends less on the volume of paper you send than on whether the reviewer can see the actual images, the confirmed pathology and the trend of your liver function over time. Gather the imaging discs or full DICOM files, the pathology report and slides or blocks where available, and dated blood results, then state the one decision you need help with.

Go to the practical guidance ↓
AI illustration: Medical paperwork, blood sample tubes, microscope slides, and a checklist on a clipboard on a wooden desk.
AI-generated illustration for care planning; not a photograph of a real patient, clinician or hospital, and not a diagnostic image.
In this guide

Start with the decision, not the folder

A second opinion is only as useful as the question behind it. "Is there anything else?" invites a vague reply. "My tumour was called unresectable here; is resection or ablation technically possible, and what would need to be true?" gives a hepatobiliary team something to test against your records.

Write your question in two or three sentences before you collect anything. Typical liver cancer questions include whether the imaging is being interpreted the same way, whether the pathology diagnosis and staging are agreed, whether a treatment already proposed is appropriate for your liver function, and whether a different local approach is technically feasible. These are different questions and may need different specialists.

Keep the question clinical, not commercial. A reviewer who knows you are weighing a trip to China can still give a records-based view, but the opinion should stand on the medicine. Cost and logistics come later, once you know whether travelling would change anything.

One practical caution: if you have new pain, fever, confusion, vomiting blood or rapidly worsening jaundice, seek local urgent care rather than waiting for an overseas review. A records review is not an emergency service.

Imaging: send the source files, not the report alone

Liver cancer assessment leans heavily on multiphase imaging, typically contrast-enhanced CT or MRI of the liver, because the diagnosis and the description of tumour number, size and position depend on how the lesion behaves across phases. A written radiology report summarises that, but a reviewer who wants to judge resectability or ablation feasibility needs to see the images.

Ask your imaging centre for the original DICOM files on disc or via a secure download link, not screenshots or photographs of a screen. Include every liver-relevant study you have, with dates, so the reviewer can see change over time. If you have had ultrasound, contrast-enhanced ultrasound, CT, MRI or a PET study, list them all and send what exists.

Keep the radiology reports alongside the files. Reports often record measurements, prior comparisons and technical limitations that help the reviewer interpret the images. If a study was done at a different hospital, say so, because technique and contrast protocols can differ.

Do not assume a scan must be repeated before anyone will look at your case. Whether new imaging is needed is a clinical decision for the treating team, and it may depend on how old the study is and what has changed since. Ask the reviewer what they would need rather than ordering tests yourself.

Pathology: the diagnosis under the images

If you have had a biopsy, resection or transplant-related pathology, the report is central. Send the full report, including the specimen description, the microscopic diagnosis, grade, any vascular invasion noted, margins and immunohistochemistry results. A short summary typed by someone else is not a substitute.

Where possible, ask whether pathology slides or paraffin blocks can be released for review. A reviewing pathologist may want to examine the original material rather than read a report, particularly if the diagnosis is uncertain or the tumour type matters for treatment choice. Release procedures and any charges are set by the holding hospital or laboratory, so confirm them directly.

Be clear about what the pathology does and does not establish. A biopsy samples part of a lesion; it may not capture the whole tumour. If no tissue diagnosis exists and imaging has been used to characterise the lesion, say so plainly rather than implying a confirmed histology you do not have.

If you have had treatment already, include pathology from any subsequent surgery, because it may change the picture.

Liver function, viral status and the trend that matters

In liver cancer, the state of the underlying liver often shapes what is possible as much as the tumour does. Send dated blood results rather than a single set: liver function tests, bilirubin, albumin, clotting studies and a full blood count. A trend over weeks or months tells a reviewer more than one snapshot.

Include results relevant to the cause of the liver disease where they exist: hepatitis B or C status and viral load, and any record of antiviral treatment. If cirrhosis has been assessed by elastography, imaging or a clinical score, include that too. These records help the team judge reserve and risk, though the final assessment remains theirs.

List your current medicines, including anticoagulants, antivirals and anything bought over the counter, with doses. Do not stop or change any medicine in preparation for a review; that is a decision for your prescriber.

A short, dated summary of your treatment history is genuinely useful: what was done, when, and what the response was. Keep it factual and separate from your own interpretation.

How a records-based review differs from being seen in person

A review of records can address whether the imaging and pathology have been read consistently, whether the staging is coherent, and whether the proposed plan aligns with recognised approaches for your disease pattern. It can identify options worth discussing. It cannot examine you, and it cannot confirm fitness for a procedure or guarantee that a hospital will accept you for treatment.

That distinction matters when you are deciding whether to travel. A records-based opinion may support a decision to seek an in-person assessment in China, or it may suggest that the appropriate next step is closer to home. Either outcome is useful. What it should not be treated as is a booking confirmation.

If your case is complex, involving for example both liver surgery and oncology questions, a review drawing on more than one specialty may be more informative than a single opinion. Ask what specialties would be involved and what the reviewer will actually receive.

For context on how cancer records are assessed for overseas patients, see the cancer staging review reference and the oncology specialty page.

Related treatment reference

Sending records safely and the next step

Share records through a secure channel agreed with the receiving service, and avoid sending passport numbers, payment details or a complete archive in a first message. A brief summary of the diagnosis, the question and what records exist is enough to begin. Ask how the provider prefers large imaging files to be transferred before you upload anything.

An initial enquiry with ChinaSpecialistCare is free. Our team checks the available diagnosis, records and your main question, identifies missing information and suggests a relevant next step. That is non-clinical intake, not a specialist opinion, and it does not establish hospital acceptance or treatment availability. A proxy consultation, where a doctor takes your records to a relevant hospital specialist while you remain at home, is optional and not a prerequisite for care.

Before any paid review, ask in writing what the reviewer will receive, which specialties are involved, what the output will look like and what the fee covers. Then decide. The hospital and its clinicians decide suitability, and any treatment plan or estimate requires their individual assessment.

Sources & scope of this guide

References and official service information relevant to this guide.

  1. Related treatment reference
  2. Primary Liver Cancer Treatment (PDQ®) - NCI
  3. Overview | Haematological cancers: improving outcomes | Guidance | NICE
  4. Childhood Liver Cancer Treatment (PDQ®) - NCI
  5. Bile Duct Cancer (Cholangiocarcinoma) Treatment (PDQ®) - NCI
  6. Liver (Hepatocellular) Cancer Prevention (PDQ®) - NCI

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.